Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“We summarized the guideline recs for anticoagulant and antiplatelettherapy in ACS and compared them with prior recs in ACCinTouch, AHAScience and escardio guidelines. Writing Committee and also a great team who made this summary possible.”
Title: Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations
Auhors: Behnood Bikdeli, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, Renato D. Lopes, Harvey D. White, Philippe Gabriel Steg, Gregory Piazza, Rasha K. Al-Lamee, David J. Cohen, Roxana Mehran, and Harlan M. Krumholz

Read the full article here.
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders
-
Jul 11, 2026, 15:03Dino Mehic: Paris Welcomes the Global Hemostasis Community at ISTH 2026
-
Jul 11, 2026, 14:55Carsten Deppermann: An Inspiring Perspective on Scientific Discovery
-
Jul 11, 2026, 14:47Isabella Presch: Arrived in Amazing Paris For ISTH 2026
-
Jul 11, 2026, 14:12Riten Kumar: The Opening Day Experience at ISTH 2026
-
Jul 11, 2026, 13:44Mary Cushman: A Decade After the RPTH Journal Launch at ISTH 2026
-
Jul 11, 2026, 11:31Acute DVT Management and the Role of Interventions Beyond Anticoagulation: Insights From ISTH 2026
-
Jul 11, 2026, 09:48Kathleen Freson: Leaving to Paris For a Sunny ISTH 2026 Meeting